• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Amino acid substitutions at position 312 in the seventh hydrophobic segment of the beta 2-adrenergic receptor modify ligand-binding specificity.

作者信息

Suryanarayana S, Kobilka B K

机构信息

Howard Hughes Medical Institute, Stanford University Medical Center, California 94305.

出版信息

Mol Pharmacol. 1993 Jul;44(1):111-4.

PMID:8101966
Abstract

We previously reported that Asn312 of the beta 2-adrenergic receptor and Asn385 in the homologous position in the 5-hydroxytryptamine1A receptor are important for binding to a class of beta-adrenergic receptor antagonists including propranolol and alprenolol. We proposed that the asparagine may be forming a hydrogen bond with the phenoxy oxygen common to these ligands. To further test this hypothesis we made alanine, threonine, phenylalanine, and glutamine substitutions at position 312 in the beta 2-adrenergic receptor. We observed that substitution with amino acids that permit formation of hydrogen bonds (threonine and glutamine) supported binding to aryloxyalkylamines, whereas substitution with amino acids that cannot form hydrogen bonds (alanine and phenylalanine) did not permit binding to these compounds. We were surprised to find that two of these substitutions led to an increase in affinity for alpha-adrenergic ligands. Substitution with glutamine and threonine at position 312 led to a 11-15-fold increase in affinity for yohimbine and enabled p-aminoclonidine to act as an agonist. These results further emphasize the role of position 312 in the formation of the ligand binding site for multiple ligands.

摘要

相似文献

1
Amino acid substitutions at position 312 in the seventh hydrophobic segment of the beta 2-adrenergic receptor modify ligand-binding specificity.
Mol Pharmacol. 1993 Jul;44(1):111-4.
2
The binding of propranolol at 5-hydroxytryptamine1D beta T355N mutant receptors may involve formation of two hydrogen bonds to asparagine.普萘洛尔与5-羟色胺1Dβ T355N突变体受体的结合可能涉及与天冬酰胺形成两个氢键。
Mol Pharmacol. 1996 Jan;49(1):198-206.
3
Identification of a single amino acid residue responsible for the binding of a class of beta-adrenergic receptor antagonists to 5-hydroxytryptamine1A receptors.
Mol Pharmacol. 1992 Apr;41(4):695-8.
4
Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding.参与α1-肾上腺素能受体亚型选择性拮抗剂结合的关键细胞外环残基的鉴定。
Mol Pharmacol. 1996 Nov;50(5):1118-26.
5
Phenylalanine in the second membrane-spanning domain of alpha 1A-adrenergic receptor determines subtype selectivity of dihydropyridine antagonists.α1A - 肾上腺素能受体第二个跨膜结构域中的苯丙氨酸决定二氢吡啶拮抗剂的亚型选择性。
Biochemistry. 1996 Nov 12;35(45):14312-7. doi: 10.1021/bi961024e.
6
Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.一些新合成的苯乙醇胺和苯氧丙醇胺化合物对重组人β-和α1-肾上腺素能受体亚型的结合亲和力比较。
J Pharm Pharmacol. 2005 Jan;57(1):75-81. doi: 10.1211/0022357055074.
7
Potent and selective human beta(3)-adrenergic receptor antagonists.强效且选择性的人β(3) - 肾上腺素能受体拮抗剂。
J Pharmacol Exp Ther. 1999 Aug;290(2):649-55.
8
A new approach to docking in the beta 2-adrenergic receptor that exploits the domain structure of G-protein-coupled receptors.一种利用G蛋白偶联受体结构域结构对β2肾上腺素能受体进行对接的新方法。
J Med Chem. 1997 Nov 21;40(24):3871-86. doi: 10.1021/jm960647n.
9
Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.鉴定对于配体与人5-羟色胺1A血清素受体结合重要的残基。
Mol Pharmacol. 1993 Apr;43(4):516-20.
10
Folding and binding integrity of variants of a prototype ligand-binding module from the LDL receptor possessing multiple alanine substitutions.具有多个丙氨酸取代的低密度脂蛋白受体原型配体结合模块变体的折叠和结合完整性。
Biochemistry. 2005 Apr 5;44(13):5075-85. doi: 10.1021/bi047575j.

引用本文的文献

1
Distinct binding conformations of epinephrine with α- and β-adrenergic receptors.肾上腺素与α-和β-肾上腺素能受体的不同结合构象。
Exp Mol Med. 2024 Sep;56(9):1952-1966. doi: 10.1038/s12276-024-01296-x. Epub 2024 Sep 2.
2
VirtuousPocketome: a computational tool for screening protein-ligand complexes to identify similar binding sites.VirtuousPocketome:一种用于筛选蛋白-配体复合物以识别相似结合位点的计算工具。
Sci Rep. 2024 Mar 15;14(1):6296. doi: 10.1038/s41598-024-56893-7.
3
L-DOPA and Droxidopa: From Force Field Development to Molecular Docking into Human β-Adrenergic Receptor.
左旋多巴和屈昔多巴:从力场开发到分子对接入人β-肾上腺素能受体
Life (Basel). 2022 Sep 6;12(9):1393. doi: 10.3390/life12091393.
4
Analysis of L-DOPA and droxidopa binding to human β-adrenergic receptor.分析 L-DOPA 和 droxidopa 与人β-肾上腺素能受体的结合。
Biophys J. 2021 Dec 21;120(24):5631-5643. doi: 10.1016/j.bpj.2021.11.007. Epub 2021 Nov 10.
5
β-Adrenergic Receptor Conformational Response to Fusion Protein in the Third Intracellular Loop.β-肾上腺素能受体在第三细胞内环中对融合蛋白的构象反应。
Structure. 2016 Dec 6;24(12):2190-2197. doi: 10.1016/j.str.2016.09.015. Epub 2016 Nov 10.
6
Agonist binding by the β2-adrenergic receptor: an effect of receptor conformation on ligand association-dissociation characteristics.β2 - 肾上腺素能受体的激动剂结合:受体构象对配体结合 - 解离特性的影响
Eur Biophys J. 2015 Apr;44(3):149-63. doi: 10.1007/s00249-015-1010-4. Epub 2015 Mar 1.
7
Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.通过对接和分子动力学模拟研究芬特罗对映异构体和衍生物与 β₂-肾上腺素能受体结合位点的分子相互作用。
J Mol Model. 2013 Nov;19(11):4919-30. doi: 10.1007/s00894-013-1981-y. Epub 2013 Sep 17.
8
A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.胺能 G 蛋白偶联受体的结构化学生物基因组学分析:组胺受体配体设计的启示。
Br J Pharmacol. 2013 Sep;170(1):101-26. doi: 10.1111/bph.12248.
9
The structural basis of G-protein-coupled receptor signaling (Nobel Lecture).G蛋白偶联受体信号传导的结构基础(诺贝尔演讲)
Angew Chem Int Ed Engl. 2013 Jun 17;52(25):6380-8. doi: 10.1002/anie.201302116. Epub 2013 May 6.
10
Ring substituents on substituted benzamide ligands indirectly mediate interactions with position 7.39 of transmembrane helix 7 of the D4 dopamine receptor.取代苯甲酰胺配体上的环取代基间接介导与 D4 多巴胺受体跨膜螺旋 7 第 7.39 位的相互作用。
J Pharmacol Exp Ther. 2012 Aug;342(2):472-85. doi: 10.1124/jpet.112.193979. Epub 2012 May 15.